Real-world evidence as a strategic access lever in rare disease drug development
Real-world evidence has an increasingly important role to play in rare disease drug development and market access. In a recent webinar, industry experts explain how real-world data and patient-centric support can shape regulatory success and sustainable reimbursement.
